Paper899779
Treatment of septicaemia in the newborn infant: choice of initial antimicrobial drugs and the role of exchange transfusion.
Töllner U and 3 others. Acta Paediatr Scand, 1977. Cited by 38 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Treatment of septicaemia in the newborn infant: choice of initial antimicrobial drugs and the role of exchange transfusion. Papers, record 899779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/899779
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of septicaemia in the newborn infant: choice of initial antimicrobial drugs and the role of exchange transfusion.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Exchange Transfusion, Whole Blood | Major topic |
| Infant, Newborn, Diseases | Major topic |
| Sepsis | Major topic |
| Bacterial Infections | |
| Humans | |
| Infant, Newborn | |
| Prognosis |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,268,331 | Exchange Transfusion in Neonatal Sepsis: A Narrative Literature Review of Pros and Cons. | J Clin Med | 2022 | https://conductscience.org/library/papers/35268331 | PubMed |
| 34,351,474 | The effect of exchange transfusion on mortality in neonatal sepsis: a meta-analysis. | Eur J Pediatr | 2022 | https://conductscience.org/library/papers/34351474 | PubMed |
| 27,171,076 | Exchange Transfusion in the Treatment of Neonatal Septic Shock: A Ten-Year Experience in a Neonatal Intensive Care Unit. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27171076 | PubMed |
| 26,211,411 | Double Volume Exchange Transfusion in Severe Neonatal Sepsis. | Indian J Pediatr | 2016 | https://conductscience.org/library/papers/26211411 | PubMed |
| 19,063,731 | The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial. | BMC Pregnancy Childbirth | 2008 | https://conductscience.org/library/papers/19063731 | PubMed |
| 7,152,593 | A comparative study on the value of exchange and blood transfusion in the management of severe neonatal septicemia with sclerema. | Indian J Pediatr | 1982 | https://conductscience.org/library/papers/7152593 | PubMed |
| 7,128,642 | Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. | Eur J Pediatr | 1982 | https://conductscience.org/library/papers/7128642 | PubMed |
| 6,376,366 | Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections. | Infection | 1984 | https://conductscience.org/library/papers/6376366 | PubMed |
| 3,902,656 | Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections. | Infection | 1985 | https://conductscience.org/library/papers/3902656 | PubMed |
| 3,042,622 | Neonatal septicemia. | Indian J Pediatr | 1988 | https://conductscience.org/library/papers/3042622 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/899779
GET https://conductscience.org/api/papers/v1/899779/authors